www.fdanews.com/articles/70351-dexcom-increases-ipo-pricing
DexCom Increases IPO Pricing
March 25, 2005
Venture-backed glucose monitoring systems maker DexCom has bumped up the value of its initial public offering (IPO) by 8 percent to $75.7 million. The San Diego, Calif.-based company set the terms of the 4.7 million share offering at $12 to $14 an issue. On Feb. 1, DexCom estimated the IPO's value at $70 million.